Yahoo Web Search

    • MacroGenics Announces Presentations at the 2021 AACR Annual Meeting

      Morningstar· 6 days ago

      ROCKVILLE, MD, April 10, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced